2m 2m 2m 2m 2m 2m 2m
THC Therapeutics (THCT)
OTC
$0.0009-$0.002 (-70.00%)
Price as of Jun 22, 2026- $34,979.00Market Cap
- 800.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
THC Therapeutics (THCT)
$0.0009-$0.002 (-70.00%)
THCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | -$0.002 (-70.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 1,000 | ||
30-Day Average Volume | 5,001 | ||
1-Week Change | -70.00% | ||
1-Month Change | -35.71% | ||
1-Year Change | 800.00% | ||
3-Year Change | -67.86% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 38.9M | ||
Total Assets | $10,648.00 | ||
Market Cap | $34,979.00 | ||
Enterprise Value | $1.3M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$281,724.00 | ||
Free Cash Flow | -$814.00 | ||
EBIT | -$194,968.00 | ||
EBITDA | -$194,617.00 | ||
Net Working Capital | -$3.8M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -0 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -43 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 5 : 1 | ||
Last Split Date | 03/13/2012 | ||